Olema Oncology to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Olema Oncology (Nasdaq: OLMA), a clinical-stage biopharmaceutical company developing targeted therapies for breast cancer and other cancers, will participate in three September 2026 investor conferences in New York. Management will join fireside chats at Citi’s Biopharma Back to School Conference on September 10, the Morgan Stanley Global Healthcare Conference on September 15, and the H.C. Wainwright Global Investment Conference on September 16. Live webcasts and, where allowed, recordings of these sessions will be accessible through the Events and Presentations section of Olema’s investor relations website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:

Citi 2026 Biopharma Back to School Conference
Date and Time: September 10, 2026 at 1 p.m. ET
Format: Fireside Chat
Location: New York, NY

Morgan Stanley 24th Annual Global Healthcare Conference
Date and Time: September 15, 2026 at 1:50 p.m. ET
Format: Fireside Chat
Location: New York, NY

H.C. Wainwright 28th Annual Global Investment Conference
Date and Time: September 16, 2026 at 9:30 a.m. ET
Format: Fireside Chat
Location: New York, NY

Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.

About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor antagonist (CERAN) and a selective estrogen receptor degrader (SERD), currently in two Phase 3 clinical trials. In addition, Olema is developing OP-3136, a potent lysine acetyltransferase 6 (KAT6) inhibitor, now in a Phase 1 clinical study. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit www.olema.com.

Media and Investor Relations Contact
Courtney O’Konek
Vice President, Corporate Communications
Olema Oncology
media@olema.com

FAQ

What investor conferences will Olema Oncology (NASDAQ: OLMA) attend in September 2026?

Olema Oncology will attend three conferences in New York in September 2026. According to Olema, these are the Citi 2026 Biopharma Back to School Conference, the Morgan Stanley 24th Annual Global Healthcare Conference, and the H.C. Wainwright 28th Annual Global Investment Conference.

When is Olema Oncology presenting at the Citi 2026 Biopharma Back to School Conference (OLMA)?

Olema Oncology is scheduled for a fireside chat on September 10, 2026, at 1 p.m. ET. According to Olema, this appearance will take place in New York, NY, with a webcast available via its investor relations website, subject to host permissions.

What is the date and time of Olema Oncology’s session at the Morgan Stanley Global Healthcare Conference 2026?

Olema Oncology will participate in a fireside chat on September 15, 2026, at 1:50 p.m. ET. According to Olema, the event will be held in New York, NY, with live or recorded webcast access on its investor relations site, as permitted.

When will Olema Oncology present at the H.C. Wainwright 28th Annual Global Investment Conference (OLMA)?

Olema Oncology’s fireside chat is scheduled for September 16, 2026, at 9:30 a.m. ET. According to Olema, the session will occur in New York, NY, and a webcast or replay may be available through its investor relations website.

How can investors access Olema Oncology (NASDAQ: OLMA) webcasts from the September 2026 conferences?

Investors can access live webcasts and recordings, where allowed, through Olema’s investor relations site. According to Olema, presentations will be posted in the Events and Presentations section at ir.olema.com, subject to each event host’s permissions.